Last Updated: May 31, 2026

Suppliers and packagers for miebo


✉ Email this page to a colleague

« Back to Dashboard


miebo

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675 NDA Bausch & Lomb Incorporated 24208-377-01 1 BOTTLE in 1 CARTON (24208-377-01) / 3 mg in 1 BOTTLE 2023-05-18
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675 NDA Bausch & Lomb Incorporated 24208-377-05 1 BOTTLE in 1 CARTON (24208-377-05) / 3 mg in 1 BOTTLE 2023-05-18
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675 NDA Bausch & Lomb Incorporated 24208-377-06 1 BOTTLE in 1 CARTON (24208-377-06) / 1.6 mg in 1 BOTTLE 2023-05-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Who Supplies MIEBO (perfluorohexyloctane) for Ophthalmic Use?

Last updated: April 26, 2026

Which companies supply MIEBO (perfluorohexyloctane) in the supply chain?

MIEBO is the brand name for perfluorohexyloctane ophthalmic solution. The drug’s commercial supply chain centers on Bausch + Lomb for US commercialization and distribution.

Who is the manufacturer (drug product) for MIEBO?

Bausch + Lomb is the labeled commercial manufacturer for MIEBO in the United States.

Role Company What it does
Marketing authorization holder / distributor (US) Bausch + Lomb Commercial distribution of MIEBO ophthalmic solution
Drug product manufacturer (as listed in US product labeling) Bausch + Lomb Produces and/or supplies the finished ophthalmic product as per product labeling

Source: US label for MIEBO (perfluorohexyloctane ophthalmic solution), which names Bausch + Lomb in the product labeling context for distribution and manufacturing. [1]

Who supplies the active ingredient (API) for MIEBO?

No supplier-by-name for perfluorohexyloctane (API) is provided in the publicly available product labeling for MIEBO. The label identifies the active ingredient (perfluorohexyloctane) but does not name an API manufacturer or named contract API supplier. [1]

Who supplies packaging and finished-dose manufacturing services (CDMO) for MIEBO?

No named contract manufacturing organization (CMO/CDMO) or packaging supplier is identified in the publicly available product labeling for MIEBO. The label provides the commercial manufacturer/distributor name context without listing specific third-party manufacturing and packaging contractors. [1]


What facts matter for procurement and partner screening?

1) The only supplier identification that is explicit in the US label

Supplier-type item Named company in label Evidence
Finished product distributor/manufacturer (US labeling context) Bausch + Lomb MIEBO prescribing information identifies Bausch + Lomb in the product labeling context for the marketed product. [1]

2) What is not named in the label

Supplier-type item Named company in label Evidence
API manufacturer Not named Product label names API as perfluorohexyloctane but does not disclose an API supplier. [1]
CMO/CDMO for drug product Not named No third-party manufacturing entity is identified in label. [1]
Packaging supplier Not named No packaging contract entity is disclosed in label. [1]

How should sourcing decisions be structured for MIEBO-related programs?

Procurement stance

  • Treat Bausch + Lomb as the primary contracting and distribution counterpart for MIEBO procurement under US commercial terms. [1]
  • For any downstream or programmatic work (relabeling, comparability studies, generic development, or supply diversification), design supplier due diligence around API and manufacturing layers that are not disclosed in the US label. [1]

Due diligence scope (what you must verify in supplier documentation)

  • API origin and traceability for perfluorohexyloctane (manufacturer-of-record, CoA, batch genealogy)
  • Finished-dose manufacturing-of-record for drug product (site and batch traceability)
  • Sterility assurance and container closure system validation for the ophthalmic formulation
  • Regulatory documentation alignment with the US marketing application and label claims

These items are necessary because the label does not disclose API, CMO, or packaging suppliers by name. [1]


Key Takeaways

  • Bausch + Lomb is the named company in US MIEBO product labeling in the context of commercialization and drug product supply/distribution. [1]
  • The public US prescribing information does not name an API supplier for perfluorohexyloctane, nor any named CMO/CDMO or packaging supplier. [1]
  • Any supplier diversification or partnership targeting API or manufacturing layers requires verification beyond label-level disclosures.

FAQs

1) Is MIEBO manufactured by Bausch + Lomb?

Yes. The US product labeling identifies Bausch + Lomb in the product context for the marketed ophthalmic drug. [1]

2) Who makes the perfluorohexyloctane active ingredient in MIEBO?

The US MIEBO prescribing information does not disclose a named API manufacturer for perfluorohexyloctane. [1]

3) Are contract manufacturing or packaging suppliers listed on the MIEBO label?

No. The US product labeling does not list specific third-party CMO/CDMO or packaging suppliers by name. [1]

4) Who is the best counterpart to source MIEBO supply for US distribution?

Bausch + Lomb is the explicit company referenced in US labeling for the marketed product. [1]

5) Does the MIEBO label specify manufacturing sites?

The cited public label provides the company context but does not provide a named third-party site list in the supplier sense addressed here. [1]


References

[1] U.S. Food and Drug Administration. MIEBO (perfluorohexyloctane) ophthalmic solution: Prescribing information. FDA label.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.